Noninvasive biomarkers FibroTest and ActiTest versus liver biopsy in chronic hepatitis C patients: the Middle East experience

BACKGROUND: The aim of this study was to compare noninvasive biomarkers, FibroTest and ActiTest in predicting fibrosis stage and inflammation grade in chronic hepatitis C (CHC) patients with liver biopsy (LB). METHODS: In 107 patients with CHC, levels of six serum biomarkers (alanine aminotransferas...

Descripción completa

Detalles Bibliográficos
Autores principales: Yakoob, Rafie, Bozom, Issam Al, Thandassery, Ragesh Babu, Rahman, Mohamed Osman Abdel, Derbala, Moutaz F., Mohannadi, Muneera J. Al, John, Anil K., Sharma, Manik, Wani, Hamidulla, Kaabi, Saad Al
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hellenic Society of Gastroenterology 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4367218/
https://www.ncbi.nlm.nih.gov/pubmed/25830472

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4367218/
https://www.ncbi.nlm.nih.gov/pubmed/25830472

Ejemplares similares